Taiyen Biotech Co Ltd
TWSE:1737
Taiyen Biotech Co Ltd
TWSE:1737
Price:
32.2
TWD
0.47%
Market Closed
Market Cap:
NT$6.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Taiyen Biotech Co Ltd
TWSE:1737
|
TW |
|
H
|
Hansol IOnes Co Ltd
KOSDAQ:114810
|
KR |
|
Dah Sing Financial Holdings Ltd
HKEX:440
|
HK |
|
Il Sole 24 Ore SpA
MIL:S24
|
IT |
|
R
|
RA Global Services Inc
OTC:RAGL
|
US |
|
R
|
REC Silicon ASA
OSE:RECSI
|
NO |
|
O
|
Oldfields Holdings Ltd
ASX:OLH
|
AU |
|
R
|
R S Software (India) Ltd
BSE:517447
|
IN |
|
Y
|
Youngwoo DSP Co Ltd
KOSDAQ:143540
|
KR |
|
Central China Securities Co Ltd
SSE:601375
|
CN |
|
D
|
Direct Finance of Direct Group 2006 Ltd
TASE:DIFI
|
IL |
|
PC Depot Corp
TSE:7618
|
JP |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Taiyen Biotech Co Ltd's stock price target?
Not Available
Taiyen Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Taiyen Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-3%
-3%
For the last 14 years the
compound annual growth rate for
Taiyen Biotech Co Ltd's operating income is
5%.
The projected
CAGR
for the next 10 years is
-3%.
What is Taiyen Biotech Co Ltd's Net Income forecast?
Projected CAGR
-2%
-2%
For the last 14 years the
compound annual growth rate for
Taiyen Biotech Co Ltd's net income is
5%.
The projected
CAGR
for the next 10 years is
-2%.
